Novel ERG for Detection of Hydroxychloroquine Retinopathy

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Hydroxychloroquine Retinopathy
Interventions
DIAGNOSTIC_TEST

Hand-Held Full-Field Skin-Electrode Electroretinography (Device to be evaluated)

RETEval Complete hand-held electroretinogram

DIAGNOSTIC_TEST

Trolley-Mounted Multifocal Skin-Electrode Electroretinography (Device to be evaluated)

UTAS multifocal electroretinogram

DIAGNOSTIC_TEST

Spectral-Domain Optical Coherence Tomography (Standard of Care test)

Heidelberg Engineering Spectralis Spectral-Domain Optical Coherence Tomography (macular structural scan)

DIAGNOSTIC_TEST

Macular Autofluorescence (Standard of Care test)

Heidelberg Engineering Spectralis Autofluorescence imaging (macular structural image)

Trial Locations (1)

SE5 9RS

RECRUITING

King's College Hospital, London

All Listed Sponsors
collaborator

LUPUS UK

UNKNOWN

collaborator

King's College Hospital Charity

UNKNOWN

lead

King's College Hospital NHS Trust

OTHER